Evidence map›Paper›PMID 40964378›Full record

ArticlebioRxiv : the preprint server for biology2025

Loss of presenilin 2 function age-dependently increases susceptibility to kainate-induced acute seizures and blunts hippocampal kainate-type glutamate receptor expression.

Larissa Robinson-Cooper, Stephanie Davidson, Rami Koutoubi, Kangni Zhang, Hannah Park, Melissa Barker-Haliski

Abstract readPreprint
In one paragraph

Article in bioRxiv : the preprint server for biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

6 authors.

Larissa Robinson-CooperDepartment of Pharmaceutics, School of Pharmacy, University of Washington.
Stephanie DavidsonDepartment of Pharmaceutics, School of Pharmacy, University of Washington.
Rami KoutoubiDepartment of Pharmaceutics, School of Pharmacy, University of Washington.
Kangni ZhangDepartment of Pharmaceutics, School of Pharmacy, University of Washington.
Hannah ParkDepartment of Pharmaceutics, School of Pharmacy, University of Washington.
Melissa Barker-HaliskiDepartment of Pharmaceutics, School of Pharmacy, University of Washington.ORCID 0000-0002-8175-0553

Funding

Impact of Chronic Seizures on Neuropsychiatric Comorbidities in AD-Associated ModelsR01AG067788 · NIA · UNIVERSITY OF WASHINGTON · PI BARKER-HALISKI, MELISSA LEIGH · 2020 to 2024
$1.9M
NIA NIH HHS R01 AG067788
6 · The paper itself

Abstract

Presenilin 2 (PSEN2) gene variants increase the risk of early-onset Alzheimer's disease (AD). AD patients with PSEN2 variants have increased risk of unprovoked seizures versus age-matched healthy controls, yet few studies have interrogated PSEN2 contributions to seizures, and fewer have done so with aging. PSEN2 variant mice also do not exhibit amyloid-β (Aβ) accumulation, allowing for the assessment of Aβ-independent contributions to seizure risk in AD. Critically, PSEN proteolytic capacity may regulate hippocampal kainate-type glutamate receptors (KARs), with PSEN deletion reducing KAR availability and synaptic transmission

Identifiers

PMID40964378
PMCPMC12439899

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.